in this issue
People & Business :: People/Executives
Pure Bioscience announces leadership reorganization
8:40 AM MDT | August 15, 2013 | Michael Ravenscroft
Pure Bioscience (El Cajon, CA) has announced a reorganization of its leadership. The company says that Dave Pfanzelter is returning to Pure as chairman. Pfanzelter will also serve as interim CEO, replacing Michael Krall, while the company initiates the process of recruiting a new CEO. Peter Wulff, a former CFO at Pure, has also agreed to return as CFO and COO. Pure says it has also appointed Gary Cohee to its board. "I am as excited as ever about the future of SDC [silver dihydrogen citrate, an antimicrobial] and Pure Bioscience," says Michael...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: